Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors

Japanese Journal of Clinical Oncology

Volumn 36, Issue 6, 2006, Pages 351-356

  Suzuki, Eriko ^a   Sasaki, Hidefumi ^a   Kawano, Osamu ^a   Endo, Katsuhiko ^a   Haneda, Hiroshi ^a   Yukiue, Haruhiro ^a   Kobayashi, Yoshihiro ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

EGFR; Mutation; Thymic cancer; Thymoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BIOASSAY; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; SAMPLING; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; THYMOMA; THYMUS CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; THYMOMA; THYMUS NEOPLASMS;

EID: 33745889922     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyl028     Document Type: Article

References (31)

1. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485-92.
2. Kondo K, Monden Y. Therapy for Thymic Epithelial Tumors: A Clinical Study of 1320 Patients From Japan. Ann Thoracic Surg 2003;76:878-85
3. Sonobe M, Nakagawa M, Ichinose M, Ikegami N, Nagasawa M, Sindo T. Thymoma. analysis of prognostic factors. Jpn J Thorac Cardiovasc Surg 2001;49:35-41.
4. Ogawa K, Uno T, Toita T, Onishi H, Yoshida H, Kakinohara Y, et al. Postoperative Radiotherapy for patients with completely resected thymoma. Cancer 2002;94:1405-13.
5. Venuta F, Rendina EA, Pescarmona EO, De Giacomo T, Vegna ML, Fazi P, et al. Multimodality treatment of thymoma: A prospective study. Ann Thorac Surg 1997;64: 1585-92.
6. Shin DM, Walsh GL, Komaki R, Putnam JB, Nesbitt J, Ro JY, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998;129:100-4.
7. Rikimaru K, Tadokoro K, Yamamoto T, Enomoto S, Tsuchida N. Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck. Head and Neck 1992; 14:8-13.
8. Mayer A, Takimoto M, Fritz E, Schellander G, Koller K, Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993;71:2454-60.
9. Klijn JG, Berns PM, Schmitz PI, Foekens JA. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients. Endocr Rev 1992;13:3-17.
10. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
11. Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500.
12. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaris I, et al. EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associate with sensitivity of tumor to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004;101:13306-11.
13. Hayashi Y, Ishii N, Obayashi C, Jinnai K, Haniok K, Imai Y, et al. Thymoma:tUmour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erbB and ras p21. Virchows Arch 1995;426:43-50.
14. Gilhus NE, Jones M, Turley H, Gatter KC, Nagvekar N, Newsom-Davis J, et al. Oncogene proteins and proliferation antigens in thymomas: Increased expression of epidermal growth factor receptor and Ki67 antigen. J Clin Pathol 1995;48:447-55.
15. Pescarmona E, Pisacane A, Pignatelli E, Baroni CD. Expression of epidermal and nerve growth factor receptors in human thymus and thymomas. Histopathology 1993;23:39-44.
16. Henley JD, Koukoulis GK, Loehrer PJ Sr. Epidermal growth factor receptor expression in invasive thymoma. J Cancer Res Clin Oncol 2002;128:167-170.
17. Sasaki H, Yukiue H, Sekimura A, Mizuno K, Konishi A, Fukai I, et al. Elevated serum epidermal growth factor receptor level in stage IV thymoma. Surg Today 2004;34:167-70.
18. Ionescu DN, Sasatomi E, Cieply K, Nola M, Dacic S. Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Cancer 2005;103:630-6.
19. Shi MM, Bleavins MR, de la iglesia FA. Technologies for detecting genetic polymorphisms in pharmacogenomics. Mol Diagn 1999;4:343-51.
20. Robledo R, Beggs W, Bender P. A simple and cost-effective method for rapid genotyping of insertion/deletion polymorphisms. Genomic 2003; 82:580-2.
21. Rosai J. The World Health Organization histological typing of tumours of the thymus. 2nd edn. Berlin: Springer Verlag; 1999:9-13.
22. Kosaka T, Yatabe Y, Endo H, Kuwano H, Takahashi T, Mitsudomi T. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004; 64:8919-23.
23. Lee JW, Soung YH, Kim SY, Park WS, Nam SW, Lee JY, et al. Absence of EGFR mutation in the kinase domain in common human cancer besides non-small cell lung cancer. Int J Cancer 2005;113:510-1.
24. Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y Hashiomoto J, et al. Recurrence of thymoma: Clinicopathological features, therapy and prognosis. Ann Thorac Surg 1985;39:165-9.
25. Macchiarin P, Chella A, Ducci F, Ross B, Testi C, Bevilacqu G. Neoadjuvant chemotherapy surgery, and postoperative radiation therapy for invasive thymoma. Cancer 1991;68:706-13.
26. Tateyama H, Takahashi E, Saito Y, Fukai I, Fujii Y, Niwa H, et al. Histopathologic changes of thymoma preoperatively treated with corticosteroids. Virchows Arch 2001;438:238-47.
27. Heneley JD, Cummings OW, Loehrer PJ Sr. Tyrosine kinase receptor expression in thymomas. J Cancer Res Clin Oncol 2004;130: 222-4.
28. Hejna M, Haberl I, Raderer M. Nonsurgical management of malignant thymoma. Cancer 1999;85:1871-84.
29. Sato JD, Kawano T, Le AD, Mendelsohn J, Polikoff J, Sato GH. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med 1983;1:511-29.
30. Goldenberg A, Masui H, Divgi C, Kamrath H, Pentlo K, Mendelsohn J. Imaging of human tumor genografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody. J Natl Cancer Inst 1989;81:1616-25.
31. Saltz LB, Meropol NJ, Loehrer PJ Sr, Needle MN, Kopit J, Mayer RJ. Phase II trial of cetuximab in patients with refractor colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 2004; 22:1201-8.